Docetaxel-induced mobilization of hematopoietic stem cells in a murine model
- 1 April 2000
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 28 (4) , 451-459
- https://doi.org/10.1016/s0301-472x(00)00130-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin’s lymphoma patients after combination chemotherapy and G-CSFBone Marrow Transplantation, 1997
- Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine modelBone Marrow Transplantation, 1997
- Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte‐colony‐stimulating factor: implications for yield of hematopoietic progenitor cell collectionsTransfusion, 1996
- Preclinical pharmacology of docetaxelEuropean Journal Of Cancer, 1995
- Interactions Between the Immune System and Breast CancerActa Oncologica, 1995
- Comparative Studies of Taxol and Taxotere on Tumor Growth and Lymphocyte FunctionsGynecologic Oncology, 1994
- Hematopoietic stem cellsCurrent Opinion in Immunology, 1992
- Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing MiceScience, 1992
- A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancerAustralian and New Zealand Journal of Medicine, 1992
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992